AstraZeneca and Sanofi’s Beyfortus (nirsevimab) has been approved in the European Union (EU) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants during their first RSV season. Beyfortus is the first and only single-dose RSV passive immunisation for the broad infant population, including those born healthy, at term or preterm, or with specific health conditions.

RSV is a common and highly contagious seasonal virus, infecting nearly all children by the age of two.

Indian Pharmacopoeia Commission clarifies on three new general chapters introduced in Indian Pharmacopoeia 2022 which are on Uniformity of Dosage Units, Elemental Impurities and Nitrosamine Impurities.

Indian Pharmacopoeia Commission (IPC) has published the Indian Pharmacopoeia (IP) 2022 and Hon ble Union Health Minister released the 9th edition of IP 2022 in July, 2022 in Vigyan Bhawan. New Delhi.

In-Cosmetics Asia 2022 Exhibition & Conference was held in Bangkok, Thailand from 1st to 3rd November 2022. It is regarded as an annual meeting hub for the Asia Pacific cosmetic and personal care industry, bringing together exhibiting ingredient suppliers and visiting manufacturers keen to source ingredients, learn, network and do business. This is where all areas of the cosmetics industry connect to inspire, share insights and spark potential collaborations.

THE INDIAN PHARMACEUTICAL ASSOCIATION (IPA)

For the first time Sun Pharma secured the top position by doctor prescriptions. It outperforms Mankind Pharma long stand, according to market research firm, SMSRC.

Sun Pharma is the largest Indian pharma company by capital, but Mankind Pharma was leading market rank for number of doctor prescriptions for a long time. Recently as per market research firm, SMSRC, Sun Pharma, which has topped India’s pharma retail market for years, has now become the leader in prescriptions, bolstered by an increase in field force and a sharper focus on core therapies.

Indian Pharmacopoeia Commission (IPC) is an Autonomous Institution of the Ministry of Health and Family Welfare, Govt. of India. IPC is created to set standards of drugs in the country. Its basic function is to update regularly the standards of drugs commonly required for treatment of diseases prevailing in this region. It publishes official documents for improving Quality of Medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia (IP).

The India TB Research Consortium (ITRC) has been formed to fast-track and align efforts in TB research. ITRC aims to achieve this goal through an interdisciplinary collaborative approach by harnessing national and international expertise to advance technology as well as product development by delivering effective diagnostics, shorter drug regimens, efficacious vaccines alongwith newer interventions for TB control.

Under the National Health Mission, Rajkot Corporation has announced to fill the following staff positions on temporary basis on contract basis for 11 months and to create a waiting list for the same. Validly qualified candidates have to apply online at Arogya Sathi Software link from 04/11/2022 to 11/11/2022 arogyasathi.gujarat.gov.in.

Below are the details showing the required qualification, age specification, high monthly salary and experience specification for the above post.

Indian Pharmacopoeia Commission (IPC) is an Autonomous Institution of the Ministry of Health and Family Welfare, Govt. of India. IPC is created to set standards of drugs in the country. Its basic function is to update regularly the standards of drugs commonly required for treatment of diseases prevailing in this region. It publishes official documents for improving Quality of Medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia (IP).

Lincoln Pharmaceuticals shares its presence with fellow foremost top notch excellence driven pharmaceutical producers, engaged in manufacturing and marketing several therapeutic molecules under WHO-GMP guidelines. What makes Lincoln stands apart is their commitment to deliver unsurpassed quality of innovative products for the betterment of human health. Our drugs are developed using best in class guidelines and all that at a very cost-effective rates.

Evertogen develop, manufacture and market finished dosages for companies around the world. With well-planned and equipped processes & systems in place, we cater to the requirements of our clients in a timely and cost-effective manner, bringing greater predictability to their business.  Pharmaceutical companies – pillars of the healthcare system – face multiple challenges of adhering to the imposed regulations, providing affordable generics to patients and maintaining a diverse portfolio with the constant pressure of the patent’s expiry.

BIRAC is a Schedule B Not-for-profit Section 8, Public Sector Enterprise, set up by the Department of Biotechnology, Ministry of Science & Technology as an Interface Agency to strengthen and empower the emerging Biotech industry to undertake strategic research and Innovation, addressing nationally relevant product development needs. The mandate of BIRAC is to catalyse the transformation of the rapidly growing biotechnology sector in India including med-tech towards achieving excellence at global level.

Jay Formulations Ltd is one of the fastest growing, WHO CERTIFIED, OSD Manufacturing Company. Company is expanding for EU & other Regulated markets., accordingly we are looking for the professionals with exposure in MHRA. TGA. ANVISA. PMDA & other accreditations for our Bavla Plant - Dist. Ahmedabad.

USV Private Limited is an Indian multinational pharmaceutical and biotechnology company in Mumbai, India. The company operates across 75 countries globally, and is a leading producer of Metformin in India. The company was founded by Vithal Balkrishna Gandhi to provide affordable and quality healthcare to every Indian.

Pfizer is the world's premier biopharmaceutical company taking new approaches to better health.  We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support.

In patients meeting the eligibility requirements for the DAPA-CKD trial, dapagliflozin is likely to be a cost effective treatment within the UK, German, and Spanish health care systems, as per new research.

Cancer cells have a series of features that allow the immune system to identify and attack them. However, these same cells create an environment that blocks immune cells and protects the tumour. This means that immune cells cannot reach the cancer cells to remove them. The scientific community has been working for years to increase the effectiveness of the immune system against cancer by using vaccines based on dead tumour cells.

The unreasonable use of antibiotics has pushed bacteria to develop resistance mechanisms to this type of treatment. This phenomenon, known as antibiotic resistance, is now considered by the WHO as one of the greatest threats to health. The lack of treatment against multi-resistant bacteria could bring us back to a time when millions of people died of pneumonia or salmonella. The bacteriumKlebsiella pneumoniae, which is very common in hospitals and particularly virulent, is one of the pathogens against which our weapons are becoming blunt.

Cipla Limited gets unaudited consolidated financial results for quarter ended September 30th, 2022. Differentiated pipeline unlocking and continued One-India momentum drive core revenue growth of 12 pc and expansion in EBITDA margin.

Revenue growth for the quarter was at 6 pc on a reported basis and a strong 12% on a covid adjusted base of last year; One-India Robust traction in core portfolio across therapies and business segments; 15 pc YoY ex-covid growth.